The current financial score of Elevance Health Inc is 4.84. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 51.43B, representing a year-over-year increase of 1.42%, while its net profit experienced a year-over-year increase of 14.80%.
The current valuation score of Elevance Health Inc is 8.44. Its current P/E ratio is 18.35, which is 12.00% below the recent high of 20.55 and 39.47% above the recent low of 11.11.
The current earnings forecast score of Elevance Health Inc is 7.83. The average price target is 449.28, with a high of 492.00 and a low of 393.00.
The current price momentum score of Elevance Health Inc is 4.31. Currently, the stock price is trading between the resistance level at 464.56 and the support level at 389.72, making it suitable for range-bound swing trading.
The current institutional shareholding score of Elevance Health Inc is 10.00. The latest institutional shareholding proportion is 95.17%, representing a quarter-over-quarter decrease of 2.84%.
The current risk assessment score of Elevance Health Inc is 8.28. The company's beta value is 0.68. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.